Tweet
LACK OF STATE FUNDS HINDER HEMOPHILIA TREATMENT IN ARMENIA
YEREVAN, April 17. /ARKA/. Lack of funds to buy the necessary
medicaments remains Armenia's main hindrance against hemophilia
treatment, Tanyan Khachatryan, Head of Armenian Association for
Hemophilia Patients, said Wednesday.
There are 238 people who currently suffer from hemophilia in Armenia,
of them 48 are children of up to 18 years old. The most common form of
this disease found Armenia is hemophilia A (174 patients). The State
allocates 99,000 drams per year for one patient treatment. Over the
past five years, only one patient died from a brain haemorrhage in
Armenia. The 70% of the patients have some type of disability.
"One patient annually needs from 10,000 to 12,000 International Units
(IU) of drugs, only 2,000 IU is imported to Armenia through budget
funds. Thus, the State supplies all hemophilia patients with only
400,000 IU," Khachatryan said and added that the remaining part
is bought through humanitarian aid provided by some international
organizations such as World Federation of Hemophilia and other
charity foundations.
She also added at present thirty patients need surgery in Armenia.
Senior hematologist of Armenia Smbat Dagbashyan noted Armenia produces
drugs from blood plasma, but they are ineffective in severe cases.
He noted hemophilia patients who need surgery must be provided with
expensive pre-treatment (up to 50,000 dollars) and imported drugs.
Dagbashyan added the patients with severe cases still receive treatment
through humanitarian aid.
"Over the past 4 years nearly 20 surgeries have been made in Armenia.
We also plan to make 2 surgeries annually through budget funds,"
he informed.
Hemophilia s a group of hereditary genetic disorders that impair the
body's ability to control blood clotting or coagulation, which is
used to stop bleeding when a blood vessel is broken.-0-
YEREVAN, April 17. /ARKA/. Lack of funds to buy the necessary
medicaments remains Armenia's main hindrance against hemophilia
treatment, Tanyan Khachatryan, Head of Armenian Association for
Hemophilia Patients, said Wednesday.
There are 238 people who currently suffer from hemophilia in Armenia,
of them 48 are children of up to 18 years old. The most common form of
this disease found Armenia is hemophilia A (174 patients). The State
allocates 99,000 drams per year for one patient treatment. Over the
past five years, only one patient died from a brain haemorrhage in
Armenia. The 70% of the patients have some type of disability.
"One patient annually needs from 10,000 to 12,000 International Units
(IU) of drugs, only 2,000 IU is imported to Armenia through budget
funds. Thus, the State supplies all hemophilia patients with only
400,000 IU," Khachatryan said and added that the remaining part
is bought through humanitarian aid provided by some international
organizations such as World Federation of Hemophilia and other
charity foundations.
She also added at present thirty patients need surgery in Armenia.
Senior hematologist of Armenia Smbat Dagbashyan noted Armenia produces
drugs from blood plasma, but they are ineffective in severe cases.
He noted hemophilia patients who need surgery must be provided with
expensive pre-treatment (up to 50,000 dollars) and imported drugs.
Dagbashyan added the patients with severe cases still receive treatment
through humanitarian aid.
"Over the past 4 years nearly 20 surgeries have been made in Armenia.
We also plan to make 2 surgeries annually through budget funds,"
he informed.
Hemophilia s a group of hereditary genetic disorders that impair the
body's ability to control blood clotting or coagulation, which is
used to stop bleeding when a blood vessel is broken.-0-